Preparing for China · patient guide

Records checklist for a lymphoma second opinion

For a lymphoma second opinion, the useful file is built around the pathology and the staging evidence, not around every paper you own. Send the diagnostic biopsy report with the original slides or blocks where the laboratory can release them, the imaging that established disease extent, the blood and bone marrow results, and a dated summary of treatment so far. A records-based opinion can clarify the diagnosis and options; it cannot confirm hospital acceptance or treatment availability in China.

Go to the practical guidance ↓
AI illustration: Office desk with stacked folders, clipboard with checklist, pen, plant, and coffee mug near a window showing a traditional pagoda outside.
AI-generated illustration for care planning; not a photograph of a real patient, clinician or hospital, and not a diagnostic image.
In this guide

Start with the question the second opinion must answer

A lymphoma second opinion is rarely a request for a general view. It is usually a request to settle something specific: whether the subtype on the pathology report is right, whether the staging is complete, whether the proposed regimen fits the subtype and stage, or whether a different option should be considered before the next cycle. Write that question down in one or two sentences before you assemble anything.

The question shapes the file. If the dispute is about histology, the pathology material matters most. If it is about extent of disease, the imaging and bone marrow records matter most. If it is about what has already been given and what response occurred, the treatment record and interval scans matter most. Sending a complete archive without a stated question makes the review slower and less focused.

Keep the question clinical rather than logistical. "Is this the right diagnosis and plan for me?" is answerable from records. "Can I be treated in China next month?" is not, because it depends on a hospital's own assessment and on arrangements that records alone do not settle.

Pathology: the report, the slides and the blocks

Lymphoma diagnosis rests on tissue examination, and a second opinion is most useful when the reviewing pathologist can look at the actual material rather than a typed summary. Ask your diagnosing laboratory what it can release: the original haematoxylin and eosin stained slides, the immunohistochemistry slides, and the paraffin blocks from which further stains can be cut. In many health systems blocks are retained by the laboratory and released on request, sometimes as unstained sections; the practical route differs by country, so confirm it with your own laboratory rather than assuming.

Include the full pathology report, not only the final line. The report usually records the specimen site, the method of biopsy, the morphological description, the immunohistochemical panel and its results, and any molecular or cytogenetic studies. Those details let a reviewer judge whether the diagnosis is adequately supported. If flow cytometry, fluorescence in situ hybridisation, or clonality studies were performed, include those reports too.

If the original biopsy was a needle core or a fine needle aspirate and the diagnosis remains uncertain, the reviewing clinician may say that the sample was not adequate for a confident classification. That is a legitimate outcome of a second opinion, and it may lead to a discussion about further biopsy rather than a revised diagnosis. Do not treat a review as a substitute for tissue that was never obtained.

A pathology review is a recognised component of lymphoma care. The National Comprehensive Cancer Network guidelines for B-cell lymphomas include review of the diagnostic material as part of the workup, and the World Health Organization classification, now in its fifth edition, sets out the entities and the immunophenotypic and genetic features that distinguish them. A reviewer working from a report alone is at a disadvantage compared with one who has the slides.

Staging records: imaging, marrow and baseline bloods

Lymphoma staging combines imaging with clinical and laboratory findings. The Lugano classification, published by Cheson and colleagues in the Journal of Clinical Oncology, sets out how computed tomography and positron emission tomography are used and how response is assessed. Send the imaging reports and, where available, the images themselves on disc or through a shareable link, with the dates clearly marked.

For most lymphomas that are fluorodeoxyglucose-avid, baseline positron emission tomography combined with computed tomography is part of staging, and it later serves as the comparator for response assessment. Include the baseline scan report and any interim or end-of-treatment scan, each with its date. A report that says "no abnormal uptake" means little to a reviewer without knowing which scan it was and when it was done relative to treatment.

Bone marrow involvement changes stage and sometimes management. Include the bone marrow trephine report, the aspirate report if done, and any immunophenotyping or molecular studies performed on the marrow. Baseline blood tests are also part of the record: full blood count, lactate dehydrogenase, liver and kidney function, and, where relevant, viral serology such as hepatitis B and HIV testing, because these affect treatment planning and supportive care.

If a lumbar puncture or cerebrospinal fluid examination was performed, include it. Central nervous system assessment is part of staging in selected lymphomas, and the criteria for doing it depend on the subtype, the sites of disease and other risk features.

Treatment history and the current plan

A second opinion on a lymphoma that has already been treated depends heavily on an accurate treatment history. For each regimen, record the drug names, the doses, the number of cycles actually given, the dates, and any dose reductions or delays with the reason. A list of cycle numbers without drug names is not enough for a reviewer to judge whether the treatment was adequate or whether a response is expected.

Include the response assessments made during treatment, with dates: the interim scan, the end-of-treatment scan, and the report that states whether the response was complete, partial, stable or progressive. If the disease progressed, the date and the site of progression matter. If treatment was stopped early, the reason matters.

Add the current plan in writing: what the treating team proposes next, and why. A second opinion is more useful when the reviewer can see the alternative being weighed. If the proposal is a clinical trial, a transplant, or a cellular therapy, say so explicitly, because these raise separate questions about eligibility and availability that a records review can only begin to address.

Include a short medication list, including supportive drugs, anticoagulants and anything bought over the counter, plus allergies and other significant conditions. This is not bureaucracy: cardiac, renal, hepatic and infectious comorbidities influence which lymphoma regimens are suitable.

What a records-based lymphoma review can and cannot settle

A records-based review can give a reasoned opinion on whether the pathology is adequately classified, whether staging appears complete, whether the treatment given was appropriate for the subtype and stage, and what options the evidence supports. It can identify gaps, such as a missing baseline scan or an unclassified biopsy, that the treating team should address.

It cannot confirm that a particular hospital in China will accept the patient, that a specific drug or trial is available, or that a proposed treatment will be offered. Those are decisions for the receiving hospital and its clinicians, made after their own assessment. Eligibility review is not enrolment in a trial, and a review of transplant or cellular therapy records does not establish access to those treatments.

A remote opinion also cannot replace an examination. Performance status, organ function, infection status and the physical findings all influence lymphoma management, and some of these can only be assessed in person. Expect the reviewing clinician to say what remains to be confirmed.

If the patient is unwell now, with fever, breathlessness, rapid swelling or other acute symptoms, local urgent assessment comes before any international second opinion. A records review is a planned activity, not an emergency pathway.

Practical assembly and the next step

Organise the file in the order a clinician reads it: a one-page summary with the diagnosis, stage, treatment to date and the specific question; then pathology; then imaging with dates; then laboratory and marrow results; then treatment records and response assessments. Label every document with its date and its source hospital or laboratory. Where documents are not in English, ask whether a translation is needed and who will provide it; do not assume a particular hospital's language or document requirements, and confirm them with the provider you approach.

For care in China, ChinaSpecialistCare's team can check the available diagnosis, records and main question, identify missing information and suggest a relevant next step. This initial case review is free and is not a diagnosis or a promise of acceptance. A proxy consultation, in which a doctor takes the records to a relevant hospital specialist while the patient remains at home, is optional and not a prerequisite for every appointment. Hospital consultation fees are separate from coordination fees.

You can begin with a brief summary by the enquiry form, email or WhatsApp, and share the fuller records after first contact rather than sending a complete medical archive up front. The lymphoma treatment reference page sets out the wider context of lymphoma care, and the haematology specialty page describes blood cancer services. The hospital, not the coordinator, decides suitability.

A useful next step is to write your one-sentence question and list what you already hold against the categories above. Then ask for the free initial review and let the team tell you what is missing before you request slides or pay for copies.

Related treatment reference

Sources & scope of this guide

References and official service information relevant to this guide.

  1. Related treatment reference
  2. Cheson BD, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014.
  3. National Comprehensive Cancer Network. B-Cell Lymphomas, Version 2.2024.
  4. Alaggio R, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 2022.

This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.